Clearstead Advisors’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$276K Buy
121,107
+30,000
+33% +$68.4K ﹤0.01% 794
2025
Q1
$141K Hold
91,107
﹤0.01% 905
2024
Q4
$214K Sell
91,107
-5,000
-5% -$11.8K ﹤0.01% 827
2024
Q3
$349K Hold
96,107
0.01% 664
2024
Q2
$334K Buy
+96,107
New +$334K 0.01% 641